Abstract
BackgroundEdaravone dexborneol is believed to be a novel cytoprotective drug, demonstrating a synergistic combination of antioxidative and anti-inflammatory properties in animal models. The Treatment of Acute Ischaemic Stroke with Edaravone...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have